1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with malondialdehyde in 23 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (malondialdehyde) | Trials (malondialdehyde) | Recent Studies (post-2010) (malondialdehyde) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 27,849 | 1,405 | 13,922 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (21.74) | 18.7374 |
| 1990's | 11 (47.83) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeuchi, H; Mason, AD; Pruitt, BA; Sakano, T; Sanchez, J | 1 |
| Zhang, F | 1 |
| Esterbauer, H; Hurst, JS; Juergens, G; Lang, J; Slater, TF; Zollner, H | 1 |
| Csonka-Khalifah, L; Maguire, MH | 1 |
| Block, HU; Ostermann, G; Till, U | 1 |
| Bottecchia, D; Doni, MG; Fantin, G | 1 |
| Ostermann, G; Thielmann, K; Till, U | 1 |
| Chyczewski, L; Dabrowski, A; Gabryelewicz, A | 1 |
| Belogi, L; Cavallo, G; Croce, C; Guida, G; Modesti, A; Santiangeli, C; Tubaro, E | 1 |
| Isselhard, W; Minor, T | 1 |
| Chopra, K; Ganguly, NK; Gupta, S; Singh, M | 1 |
| Gupta, JB; Kalra, J; Prasad, K; Prasad, M | 1 |
| Alataş, O; Colak, O; Inal, M; Kiper, H; Sahin, A; Yaşar, B | 1 |
| Abdullaev, RIu; Gedymin, LE; Kaminskaia, GO | 2 |
| Fu, ZG; Li, HP; Li, M; Xia, XM; Xiang, Y | 1 |
| Sereni, L; Tetta, C; Wratten, ML | 1 |
| Akisu, M; Baka, M; Hüsseyinov, A; Küllahçioğlu Girgin, F; Kültürsay, N | 1 |
| Liu, J; Qin, C; Shi, H; Zhang, C; Zu, J | 1 |
| Cao, HC; Chen, XM; Xu, W | 1 |
| Aladağ, M; Ara, C; Demirel, U; Firat, S; Harputluoglu, MM; Hilmioğlu, F; Karadağ, N; Karincaoğlu, M; Temel, I; Yücel, N | 1 |
| Andreadou, I; Arkadopoulos, N; Avgerinos, E; Costopanagiotou, C; Diamantopoulou, K; Kostopanagiotou, G; Lekka, M; Nakos, G; Smyrniotis, V | 1 |
| Demopoulos, C; Giaginis, C; Gribilas, G; Karantonis, HC; Kouraklis, G; Spiliopoulou, C; Stamoulis, I; Theocharis, SE | 1 |
23 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and malondialdehyde
| Article | Year |
|---|---|
The effects of platelet-activating factor (PAF) and a PAF antagonist (CV-3988) on smoke inhalation injury in an ovine model.
Topics: Animals; Dinoprostone; Lipid Peroxidation; Male; Malondialdehyde; Phospholipid Ethers; Platelet Activating Factor; Platelet Count; Sheep; Smoke Inhalation Injury; Thromboxane B2; Time Factors | 1992 |
[Protective effect of a platelet activating factor antagonist in experimental liver injury].
Topics: Animals; Azepines; Chemical and Drug Induced Liver Injury; Endotoxins; Galactosamine; Liver; Malondialdehyde; Peroxidase; Platelet Activating Factor; Rats; Rats, Inbred Strains; Superoxide Dismutase; Triazoles | 1990 |
Effects of the lipid peroxidation product 4-hydroxynonenal on the aggregation of human platelets.
Topics: Adenosine Diphosphate; Aldehydes; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcimycin; Drug Antagonism; Fatty Acids; Glutathione; Humans; In Vitro Techniques; Malondialdehyde; Platelet Activating Factor; Platelet Aggregation; Thrombin | 1987 |
Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Chromatography, Thin Layer; Cyclooxygenase Inhibitors; Dinoprostone; Humans; In Vitro Techniques; Malondialdehyde; Microsomes; Oxygen Consumption; Platelet Activating Factor; Platelet Aggregation; Prostaglandins E; Thromboxane B2; Vinblastine | 1987 |
The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcimycin; Collagen; Humans; Kinetics; Malondialdehyde; Platelet Activating Factor; Platelet Aggregation; Thromboxane B2 | 1984 |
Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation.
Topics: Animals; Blood Physiological Phenomena; Clot Retraction; Depression, Chemical; Dipyridamole; Dose-Response Relationship, Drug; Humans; Isotonic Solutions; Malondialdehyde; Platelet Activating Factor; Platelet Aggregation; Rats; Verapamil | 1984 |
Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.
Topics: Arachidonic Acids; Blood Platelets; Drug Synergism; Humans; Malondialdehyde; Platelet Activating Factor; Platelet Aggregation | 1984 |
The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress.
Topics: Acute Disease; Amylases; Animals; Disease Models, Animal; Diterpenes; Ginkgolides; Lactones; Liver; Lung; Male; Malondialdehyde; Organ Specificity; Oxidative Stress; Pancreas; Pancreatitis; Platelet Activating Factor; Rats; Rats, Wistar; Sulfhydryl Compounds | 1995 |
Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced inflammatory bowel disease: possible mechanism of action.
Topics: Animals; Arachidonic Acid; Carbohydrate Sequence; Colitis; Colon; Gangliosides; Humans; Inflammatory Bowel Diseases; Leukotriene B4; Male; Malondialdehyde; Molecular Sequence Data; Organ Size; Pancreas; Peroxidase; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Spleen; Synovial Fluid; Trinitrobenzenesulfonic Acid | 1993 |
Platelet-activating factor antagonism enhances the liver's recovery from warm ischemia in situ.
Topics: Adenosine Triphosphate; Animals; Diterpenes; Endothelium, Vascular; Free Radicals; Ginkgolides; Ischemia; Lactones; Liver; Male; Malondialdehyde; Platelet Activating Factor; Purine-Nucleoside Phosphorylase; Rats; Rats, Wistar; Reperfusion Injury | 1993 |
Involvement of oxygen free radicals in the action of BN 52021 (PAF antagonist) to limit myocardial infarct size.
Topics: Analysis of Variance; Animals; Blood Pressure; Diterpenes; Electrocardiography; Female; Free Radicals; Ginkgolides; Glutathione Peroxidase; Heart Ventricles; Lactones; Luminescent Measurements; Male; Malondialdehyde; Myocardial Infarction; Myocardium; Neutrophils; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1993 |
Platelet-activating-factor-induced changes in cardiovascular function and oxyradical status of myocardium in presence of the PAF antagonist CV-6209.
Topics: Animals; Creatine Kinase; Dogs; Female; Free Radicals; Heart; Hemodynamics; Hydrogen-Ion Concentration; Lactates; Lipid Peroxidation; Male; Malondialdehyde; Myocardial Contraction; Myocardium; Oxygen; Platelet Activating Factor; Pyridinium Compounds; Ventricular Function, Left | 1994 |
The effect of Ginkgo biloba on the activity of catalase and lipid peroxidation in experimental strangulation ileus.
Topics: Animals; Catalase; Creatine Kinase; Flavonoids; Ginkgo biloba; Ileal Diseases; Ileum; Intestinal Obstruction; Ischemia; Ligation; Lipid Peroxidation; Malondialdehyde; Oxidation-Reduction; Phosphates; Plant Extracts; Platelet Activating Factor; Rats; Reperfusion Injury; Vasodilator Agents | 1998 |
[Features of oxidative metabolism and level of platelet activating factor in pulmonary and circulating phagocytes of tuberculosis-resistant animals at stages of experimental infection].
Topics: Animals; Biomarkers; Catalase; Disease Models, Animal; Follow-Up Studies; Guinea Pigs; Leukocytes; Macrophages, Alveolar; Malondialdehyde; Oxidative Stress; Platelet Activating Factor; Rats; Superoxide Dismutase; Tuberculosis, Pulmonary | 1998 |
Effect of chinonin on acute hypoxic pulmonary vasoconstriction in Sprague-Dawley rats.
Topics: Animals; Anti-Inflammatory Agents; Endothelin-1; Female; Free Radical Scavengers; Glycosides; Hypoxia; Male; Malondialdehyde; Phospholipases A; Phospholipases A2; Plant Extracts; Platelet Activating Factor; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Vasoconstriction; Xanthenes; Xanthones | 1998 |
[Oxidative metabolic changes, antioxidantion, and platelet activation rat phagocytes during development of experimental specific tuberculous changes].
Topics: Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Catalase; Follow-Up Studies; Guinea Pigs; Leukocytes; Macrophages, Alveolar; Malondialdehyde; Oxidation-Reduction; Phagocytes; Platelet Activating Factor; Rats; Superoxide Dismutase; Tuberculosis, Pulmonary | 1998 |
Hemolipodialysis attenuates oxidative stress and removes hydrophobic toxins.
Topics: Animals; Antioxidants; Ascorbic Acid; Bilirubin; Blood Proteins; Cattle; Extracorporeal Circulation; Free Radical Scavengers; Humans; Liposomes; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Phosphatidylcholines; Phospholipids; Platelet Activating Factor; Renal Dialysis; Serum Albumin, Bovine; Toxins, Biological; Uremia; Vitamin E | 2000 |
The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Enterocolitis, Necrotizing; Erythropoietin; Female; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Platelet Activating Factor; Probability; Rats; Rats, Wistar; Recombinant Proteins; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric | 2001 |
The effect of Ginkgo biloba extract (EGb 761) on hepatic sinusoidal endothelial cells and hepatic microcirculation in CCl4 rats.
Topics: Animals; Carbon Tetrachloride; Endothelial Cells; Endothelin-1; Ginkgo biloba; Liver; Male; Malondialdehyde; Microcirculation; Microscopy, Electron; Nitric Oxide; Phytotherapy; Plant Extracts; Plant Leaves; Platelet Activating Factor; Protective Agents; Rats; Rats, Wistar | 2004 |
Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis.
Topics: Adult; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Endotoxins; Female; Hepatitis, Viral, Human; Humans; Male; Malondialdehyde; Middle Aged; Platelet Activating Factor; Sensitivity and Specificity; Tumor Necrosis Factor-alpha | 2005 |
The effects of Gingko biloba extract on acetic acid-induced colitis in rats.
Topics: Acetic Acid; Animals; Antioxidants; Biomarkers; Colitis; Disease Models, Animal; Fibrosis; Ginkgo biloba; Intestinal Mucosa; Male; Malondialdehyde; Necrosis; Oxidative Stress; Phytotherapy; Plant Extracts; Platelet Activating Factor; Rats; Rats, Wistar | 2006 |
Acute lung injury in a rat model of intestinal ischemia-reperfusion: the potential time depended role of phospholipases A(2).
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Intestines; Lung; Male; Malondialdehyde; Phospholipases A2; Platelet Activating Factor; Pulmonary Gas Exchange; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Respiratory Distress Syndrome; Time Factors | 2008 |
Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis.
Topics: Animals; Chromatography, High Pressure Liquid; Disease Progression; Liver; Liver Cirrhosis, Experimental; Male; Malondialdehyde; Platelet Activating Factor; Rats; Rats, Wistar; Severity of Illness Index; Thioacetamide | 2010 |